Hyam Levitsky Century Therapeutics, Inc. (IPSC) insider trading activity

IPSC Quotes by TradingView

Hyam Levitsky is President of R&D of Century Therapeutics, Inc.. Currently has a direct ownership of 24,000 shares of IPSC, which is worth approximately $27,599. The most recent transaction as insider was on Mar 07, 2024, when has been sold 24,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24K
0% 3M change
n/a 12M change
Total Value Held $27,599

Hyam Levitsky Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 07 2024
BUY
Grant, award, or other acquisition
-
24,000 Added 50.0%
24,000 Common Stock

Also insider at

REPL
Replimune Group, Inc. Healthcare
Director
HL

Hyam Levitsky

President of R&D
Woburn, MA

Track Institutional and Insider Activities on IPSC

Follow Century Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IPSC shares.

Notify only if

Insider Trading

Get notified when an Century Therapeutics, Inc. insider buys or sells IPSC shares.

Notify only if

News

Receive news related to Century Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IPSC